Planning a Clinical Trial Programme for Medicinal Products for the Treatment of Axial Spondyloarthritis
The criteria for diagnosis and classification of spondyloarthritides (SpAs) have undergone significant changes over the past 10 years. The emergence of new diagnostic methods and availability of new information on the prognosis of the disease outcome made it possible to distinguish a separate group...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2021-10-01
|
| Serie: | Регуляторные исследования и экспертиза лекарственных средств |
| Soggetti: | |
| Accesso online: | https://www.vedomostincesmp.ru/jour/article/view/361 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|